Primary Research · 2008
Effectiveness of N-acetylcysteine in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis
Kelly AM, Dwamena B, Cronin P, et al. · Annals of Internal Medicine, 2008
Key finding
Meta-analysis of 41 trials found NAC associated with reduced risk of contrast-induced nephropathy, supporting clinical use of NAC for renal protection in high-risk patients undergoing contrast imaging.
About the supplement
NAC (N-Acetyl Cysteine)
Dose · mechanism · evidence grade · safety →
Read the paper
Open sourceAbout this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.